skip to content
Considerations for ensuring safety and efficacy of vaccines and therapeutic proteins manufactured by using platform approaches : summary of a workshop Preview this item
ClosePreview this item
Checking...

Considerations for ensuring safety and efficacy of vaccines and therapeutic proteins manufactured by using platform approaches : summary of a workshop

Author: Jeffrey Fox; Marilee Shelton-Davenport; India Hook-Barnard; National Research Council (U.S.). Standing Committee on Biodefense at the U.S. Department of Defense.; National Research Council (U.S.). Board on Life Sciences.
Publisher: Washington, D.C. : National Academies Press, ©2010.
Edition/Format:   eBook : Document : EnglishView all editions and formats
Summary:
On September 15, 2008, the National Academies held the workshop "Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches". The workshop was planned and organized by an ad hoc planning committee made up of members of the Standing Committee on Biodefense at the US Department of Defense. The charge to the planning committee was to bring together  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Additional Physical Format: Print version:
Considerations for ensuring safety and efficacy of vaccines and therapeutic proteins manufactured by using platform approaches.
Washington, D.C. : National Academies Press, ©2010
(OCoLC)655759707
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Jeffrey Fox; Marilee Shelton-Davenport; India Hook-Barnard; National Research Council (U.S.). Standing Committee on Biodefense at the U.S. Department of Defense.; National Research Council (U.S.). Board on Life Sciences.
ISBN: 9780309153225 0309153220 1282660438 9781282660434
OCLC Number: 659579790
Description: 1 online resource (xi, 26 pages)
Contents: Introduction --
TMTI case for versatile production platforms --
Discussion of TMTI efforts --
Platforms for large-scale monoclonal antibody production --
Presentation by Brian Kelley --
Presentation by Dane Zabriskie --
Discussion --
Suitability of platforms and supply needed --
Reducing timeline --
Manufacturing producation capacity --
Regulatory issues --
Platforms for vaccine production --
Presentation by Dave Robinson --
Discussion --
Various platforms --
Manufacturing facilities --
Regulatory issues --
Summary of key points.
Responsibility: Jeffrey Fox, Marilee Shelton-Davenport, and India Hook-Barnard, rapporteurs ; Board on Life Sciences, Division on Earth and Life Studies, National Research Council of the National Academies.

Abstract:

On September 15, 2008, the National Academies held the workshop "Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches". The workshop was planned and organized by an ad hoc planning committee made up of members of the Standing Committee on Biodefense at the US Department of Defense. The charge to the planning committee was to bring together scientists from academe, government, and the biotechnology industry to identify and discuss challenges and ideas related to the Transformational Medical Technologies Initiative's (TMTI) vision of developing countermeasures within a few months after a biologic-warfare agent is identified. The workshop focused on manufacturing processes and specifically on the development of "manufacturing platforms"--Repeatable components of manufacturing that reduce both development time and risk. An underlying assumption was that demonstrating that integrated platforms can reliably produce safe and efficacious countermeasures might shorten the regulatory approval process. Participants discussed manufacturing-related characteristics of monoclonal antibodies and vaccines. Although the planning committee understood that the TMTI efforts are broader than biologics and that TMTI platform approaches for biologics extend beyond monoclonal antibodies and vaccines, the planning committee believed that focusing on monoclonal antibodies and vaccines could illustrate some of the promise and challenges of platform approaches.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/659579790> # Considerations for ensuring safety and efficacy of vaccines and therapeutic proteins manufactured by using platform approaches : summary of a workshop
    a schema:Book, schema:MediaObject, schema:CreativeWork ;
    library:oclcnum "659579790" ;
    library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/802711471#Place/washington_d_c> ; # Washington, D.C.
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/dcu> ;
    schema:about <http://id.worldcat.org/fast/1025554> ; # Monoclonal antibodies--Therapeutic use
    schema:about <http://experiment.worldcat.org/entity/work/data/802711471#Topic/antibodies_monoclonal_therapeutic_use> ; # Antibodies, Monoclonal--therapeutic use
    schema:about <http://experiment.worldcat.org/entity/work/data/802711471#Place/united_states> ; # United States.
    schema:about <http://id.loc.gov/authorities/subjects/sh2009117086> ; # Biological warfare--United States--Safety measures
    schema:about <http://experiment.worldcat.org/entity/work/data/802711471#Topic/drug_approval> ; # Drug Approval
    schema:about <http://id.loc.gov/authorities/subjects/sh2009123884> ; # Drug approval--United States
    schema:about <http://id.worldcat.org/fast/1163573> ; # Vaccines
    schema:about <http://experiment.worldcat.org/entity/work/data/802711471#Topic/biological_warfare_prevention_&_control> ; # Biological Warfare--prevention & control
    schema:about <http://experiment.worldcat.org/entity/work/data/802711471#Topic/vaccines_united_states> ; # Vaccines--United States
    schema:about <http://experiment.worldcat.org/entity/work/data/802711471#Topic/history_military_biological_&_chemical_warfare> ; # HISTORY--Military--Biological & Chemical Warfare
    schema:about <http://id.worldcat.org/fast/832364> ; # Biological warfare--Safety measures
    schema:about <http://dewey.info/class/358.38/e22/> ;
    schema:about <http://id.worldcat.org/fast/1204155> ; # United States.
    schema:about <http://id.loc.gov/authorities/subjects/sh2010102330> ; # Monoclonal antibodies--Therapeutic use
    schema:about <http://id.worldcat.org/fast/898661> ; # Drug approval
    schema:bookFormat schema:EBook ;
    schema:contributor <http://viaf.org/viaf/132943996> ; # National Research Council (U.S.). Standing Committee on Biodefense at the U.S. Department of Defense.
    schema:contributor <http://viaf.org/viaf/122288004> ; # Marilee Shelton-Davenport
    schema:contributor <http://viaf.org/viaf/122314407> ; # India Hook-Barnard
    schema:contributor <http://viaf.org/viaf/121561049> ; # Jeffrey L. Fox
    schema:contributor <http://viaf.org/viaf/135352478> ; # National Research Council (U.S.). Board on Life Sciences.
    schema:copyrightYear "2010" ;
    schema:datePublished "2010" ;
    schema:description "On September 15, 2008, the National Academies held the workshop "Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches". The workshop was planned and organized by an ad hoc planning committee made up of members of the Standing Committee on Biodefense at the US Department of Defense. The charge to the planning committee was to bring together scientists from academe, government, and the biotechnology industry to identify and discuss challenges and ideas related to the Transformational Medical Technologies Initiative's (TMTI) vision of developing countermeasures within a few months after a biologic-warfare agent is identified. The workshop focused on manufacturing processes and specifically on the development of "manufacturing platforms"--Repeatable components of manufacturing that reduce both development time and risk. An underlying assumption was that demonstrating that integrated platforms can reliably produce safe and efficacious countermeasures might shorten the regulatory approval process. Participants discussed manufacturing-related characteristics of monoclonal antibodies and vaccines. Although the planning committee understood that the TMTI efforts are broader than biologics and that TMTI platform approaches for biologics extend beyond monoclonal antibodies and vaccines, the planning committee believed that focusing on monoclonal antibodies and vaccines could illustrate some of the promise and challenges of platform approaches."@en ;
    schema:description "Introduction -- TMTI case for versatile production platforms -- Discussion of TMTI efforts -- Platforms for large-scale monoclonal antibody production -- Presentation by Brian Kelley -- Presentation by Dane Zabriskie -- Discussion -- Suitability of platforms and supply needed -- Reducing timeline -- Manufacturing producation capacity -- Regulatory issues -- Platforms for vaccine production -- Presentation by Dave Robinson -- Discussion -- Various platforms -- Manufacturing facilities -- Regulatory issues -- Summary of key points."@en ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/802711471> ;
    schema:genre "Electronic books"@en ;
    schema:inLanguage "en" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/655759707> ;
    schema:name "Considerations for ensuring safety and efficacy of vaccines and therapeutic proteins manufactured by using platform approaches : summary of a workshop"@en ;
    schema:productID "659579790" ;
    schema:publication <http://www.worldcat.org/title/-/oclc/659579790#PublicationEvent/washington_d_c_national_academies_press_2010> ;
    schema:publisher <http://experiment.worldcat.org/entity/work/data/802711471#Agent/national_academies_press> ; # National Academies Press
    schema:url <http://ebookcentral.proquest.com/lib/rdc/detail.action?docID=3378635> ;
    schema:url <http://ebookcentral.proquest.com/lib/warw/detail.action?docID=3378635> ;
    schema:url <http://ebookcentral.proquest.com/lib/macewan-ebooks/detail.action?docID=3378635> ;
    schema:url <http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=326079> ;
    schema:url <http://books.nap.edu/openbook.php?record_id=12899> ;
    schema:url <http://ebookcentral.proquest.com/lib/columbia/detail.action?docID=3378635> ;
    schema:url <http://public.eblib.com/choice/publicfullrecord.aspx?p=3378635> ;
    schema:url <http://ebookcentral.proquest.com/lib/concordiaab-ebooks/detail.action?docID=3378635> ;
    schema:url <http://www.myilibrary.com?id=266043> ;
    schema:url <http://public.ebookcentral.proquest.com/choice/publicfullrecord.aspx?p=3378635> ;
    schema:url <http://site.ebrary.com/id/10399497> ;
    schema:url <http://www.nap.edu/catalog.php?record_id=12899> ;
    schema:url <http://ebookcentral.proquest.com/lib/gprc-ebooks/detail.action?docID=3378635> ;
    schema:url <http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=326079> ;
    schema:url <http://www.myilibrary.com?id=266043&ref=toc> ;
    schema:url <http://uclibs.org/PID/227476> ;
    schema:workExample <http://worldcat.org/isbn/9780309153225> ;
    schema:workExample <http://worldcat.org/isbn/9781282660434> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/659579790> ;
    .


Related Entities

<http://ebookcentral.proquest.com/lib/concordiaab-ebooks/detail.action?docID=3378635>
    rdfs:comment "from Ebook Central Academic Complete" ;
    rdfs:comment "(Unlimited Concurrent Users)" ;
    .

<http://ebookcentral.proquest.com/lib/gprc-ebooks/detail.action?docID=3378635>
    rdfs:comment "from Ebook Central Academic Complete" ;
    rdfs:comment "(Unlimited Concurrent Users)" ;
    .

<http://ebookcentral.proquest.com/lib/macewan-ebooks/detail.action?docID=3378635>
    rdfs:comment "from Ebook Central Academic Complete" ;
    rdfs:comment "(Unlimited Concurrent Users)" ;
    .

<http://ebookcentral.proquest.com/lib/rdc/detail.action?docID=3378635>
    rdfs:comment "from Ebook Central Academic Complete" ;
    rdfs:comment "(Unlimited Concurrent Users)" ;
    .

<http://experiment.worldcat.org/entity/work/data/802711471#Agent/national_academies_press> # National Academies Press
    a bgn:Agent ;
    schema:name "National Academies Press" ;
    .

<http://experiment.worldcat.org/entity/work/data/802711471#Place/united_states> # United States.
    a schema:Place ;
    schema:name "United States." ;
    .

<http://experiment.worldcat.org/entity/work/data/802711471#Place/washington_d_c> # Washington, D.C.
    a schema:Place ;
    schema:name "Washington, D.C." ;
    .

<http://experiment.worldcat.org/entity/work/data/802711471#Topic/antibodies_monoclonal_therapeutic_use> # Antibodies, Monoclonal--therapeutic use
    a schema:Intangible ;
    schema:name "Antibodies, Monoclonal--therapeutic use"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/802711471#Topic/biological_warfare_prevention_&_control> # Biological Warfare--prevention & control
    a schema:Intangible ;
    schema:name "Biological Warfare--prevention & control"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/802711471#Topic/history_military_biological_&_chemical_warfare> # HISTORY--Military--Biological & Chemical Warfare
    a schema:Intangible ;
    schema:name "HISTORY--Military--Biological & Chemical Warfare"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh2009117086> # Biological warfare--United States--Safety measures
    a schema:Intangible ;
    schema:name "Biological warfare--United States--Safety measures"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh2009123884> # Drug approval--United States
    a schema:Intangible ;
    schema:name "Drug approval--United States"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh2010102330> # Monoclonal antibodies--Therapeutic use
    a schema:Intangible ;
    schema:name "Monoclonal antibodies--Therapeutic use"@en ;
    .

<http://id.worldcat.org/fast/1025554> # Monoclonal antibodies--Therapeutic use
    a schema:Intangible ;
    schema:name "Monoclonal antibodies--Therapeutic use"@en ;
    .

<http://id.worldcat.org/fast/1163573> # Vaccines
    a schema:Intangible ;
    schema:name "Vaccines"@en ;
    .

<http://id.worldcat.org/fast/1204155> # United States.
    a schema:Place ;
    schema:name "United States." ;
    .

<http://id.worldcat.org/fast/832364> # Biological warfare--Safety measures
    a schema:Intangible ;
    schema:name "Biological warfare--Safety measures"@en ;
    .

<http://id.worldcat.org/fast/898661> # Drug approval
    a schema:Intangible ;
    schema:name "Drug approval"@en ;
    .

<http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=326079>
    rdfs:comment "from EBSCO Academic Collection" ;
    rdfs:comment "(Unlimited Concurrent Users)" ;
    .

<http://uclibs.org/PID/227476>
    rdfs:comment "National Academies Press" ;
    .

<http://viaf.org/viaf/121561049> # Jeffrey L. Fox
    a schema:Person ;
    schema:familyName "Fox" ;
    schema:givenName "Jeffrey L." ;
    schema:givenName "Jeffrey" ;
    schema:name "Jeffrey L. Fox" ;
    .

<http://viaf.org/viaf/122288004> # Marilee Shelton-Davenport
    a schema:Person ;
    schema:familyName "Shelton-Davenport" ;
    schema:givenName "Marilee" ;
    schema:name "Marilee Shelton-Davenport" ;
    .

<http://viaf.org/viaf/122314407> # India Hook-Barnard
    a schema:Person ;
    schema:familyName "Hook-Barnard" ;
    schema:givenName "India" ;
    schema:name "India Hook-Barnard" ;
    .

<http://viaf.org/viaf/132943996> # National Research Council (U.S.). Standing Committee on Biodefense at the U.S. Department of Defense.
    a schema:Organization ;
    schema:name "National Research Council (U.S.). Standing Committee on Biodefense at the U.S. Department of Defense." ;
    .

<http://viaf.org/viaf/135352478> # National Research Council (U.S.). Board on Life Sciences.
    a schema:Organization ;
    schema:name "National Research Council (U.S.). Board on Life Sciences." ;
    .

<http://worldcat.org/isbn/9780309153225>
    a schema:ProductModel ;
    schema:isbn "0309153220" ;
    schema:isbn "9780309153225" ;
    .

<http://worldcat.org/isbn/9781282660434>
    a schema:ProductModel ;
    schema:isbn "1282660438" ;
    schema:isbn "9781282660434" ;
    .

<http://www.worldcat.org/oclc/655759707>
    a schema:CreativeWork ;
    rdfs:label "Considerations for ensuring safety and efficacy of vaccines and therapeutic proteins manufactured by using platform approaches." ;
    schema:description "Print version:" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/659579790> ; # Considerations for ensuring safety and efficacy of vaccines and therapeutic proteins manufactured by using platform approaches : summary of a workshop
    .

<http://www.worldcat.org/title/-/oclc/659579790>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
    schema:about <http://www.worldcat.org/oclc/659579790> ; # Considerations for ensuring safety and efficacy of vaccines and therapeutic proteins manufactured by using platform approaches : summary of a workshop
    schema:dateModified "2018-02-11" ;
    void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.